BCGM Wealth Management, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1830467 LAFAYETTE, IN

Position in GILD

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$1,832,309

-$69,673 QoQ

Shares Held

14,503

+6.3% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

1.16%

of 13F equity value

Holder Rank

#861

of 2,266 holders

Holding Since

Dec 2020

9 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

BCGM Wealth Management, LLC holds $14,498,992 across 5 Drug Manufacturers - General names. GILD ranks #2 (12.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	8,946	$10,730,101
2	GILD	Gilead Sciences, Inc. This page	14,503	$1,832,309
3	PFE	Pfizer Inc	57,029	$1,373,258
4	JNJ	Johnson & Johnson	1,364	$346,415
5	AMGN	Amgen Inc	599	$216,909

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,832,309	14,503	+6.3%	Shares	Sole	2026-08-04
2026-03-31	$1,901,982	13,647	+16.2%	Shares	Sole	2026-05-05
2025-12-31	$1,441,704	11,746	+16.3%	Shares	Sole	2026-01-07
2022-03-31	$600,445	10,100	+4.3%	Shares	Sole	2022-05-02
2021-12-31	$703,445	9,688	+4.0%	Shares	Sole	2022-02-01
2021-09-30	$650,722	9,316	+9.0%	Shares	Sole	2021-11-01
2021-06-30	$588,477	8,546	+11.5%	Shares	Sole	2021-08-02
2021-03-31	$495,388	7,665	+24.9%	Shares	Sole	2021-04-21
2020-12-31	$357,425	6,135	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.